Counteracting the effects of TNF receptor‐1 has therapeutic potential in Alzheimer's disease.
- Published in:
- EMBO Molecular Medicine, 2018, v. 10, n. 4, p. 1, doi. 10.15252/emmm.201708300
- By:
- Publication type:
- Article
Works by Gorlé, Nina
Results: 6
1
2
Amyloid β Oligomers Disrupt Blood-CSF Barrier Integrity by Activating Matrix Metalloproteinases.
- Published in:
- Journal of Neuroscience, 2015, v. 35, n. 37, p. 12766, doi. 10.1523/JNEUROSCI.0006-15.2015
- By:
- Publication type:
- Article
3
Low-grade peripheral inflammation affects brain pathology in the App<sup>NL-G-F</sup>mouse model of Alzheimer's disease.
- Published in:
- Acta Neuropathologica Communications, 2021, v. 9, n. 1, p. 1, doi. 10.1186/s40478-021-01253-z
- By:
- Publication type:
- Article
4
Immunogenicity and Protection Efficacy of a Naked Self-Replicating mRNA-Based Zika Virus Vaccine.
- Published in:
- Vaccines, 2019, v. 7, n. 3, p. 96, doi. 10.3390/vaccines7030096
- By:
- Publication type:
- Article
5
The effect of aging on brain barriers and the consequences for Alzheimer's disease development.
- Published in:
- Mammalian Genome, 2016, v. 27, n. 7/8, p. 407, doi. 10.1007/s00335-016-9637-8
- By:
- Publication type:
- Article
6
Helicobacter and the Potential Role in Neurological Disorders: There Is More Than Helicobacter pylori.
- Published in:
- Frontiers in Immunology, 2021, v. 11, p. N.PAG, doi. 10.3389/fimmu.2020.584165
- By:
- Publication type:
- Article